We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comments, Opinions, and Brief Case Reports |

More Than 7 Years of Consistent Neuropathic Pain Relief in Geriatric Patients

Bradley S. Galer; Arnold R. Gammaitoni
Arch Intern Med. 2003;163(5):628. doi:10.1001/archinte.163.5.628.
Text Size: A A A
Published online


Neuropathic pain is considered one of the most refractory and disabling chronic pains that a person can experience.1 Based on randomized controlled trials, the current recommended treatments include topical local anesthetics, gabapentin, tricyclic antidepressants, and opioids.2 To our knowledge, no long-term follow-up studies have been published assessing neuropathic pain outcomes after 1 year of therapy. In the 1990s, a number of randomized, double-blind, placebo-controlled studies demonstrated the efficacy and safety of the 5% lidocaine patch (Lidoderm; Endo Pharmaceuticals Inc, Chadds Ford, Pa), a targeted peripheral analgesic, in the treatment of postherpetic neuralgia (PHN).3,4 Subjects in these trials were offered compassionate use of the lidocaine patch and have continued to use it to treat their PHN. A follow-up survey of these subjects was conducted to assess the effectiveness and patient satisfaction with the patch over long-term treatment.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption

Mean patient satisfaction with long-term 5% lidocaine patch treatment in 20 cases of postherpetic neuralgia, based on an 11-point scale, according to which −5 indicates extremely dissatisfied and +5 extremely satisfied.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

22 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles